Interleukin-11 precursor en es it fr

Interleukin-11 precursor Brand names, Interleukin-11 precursor Analogs

Interleukin-11 precursor Brand Names Mixture

  • No information avaliable

Interleukin-11 precursor Chemical_Formula

C854H1411N253O235S2

Interleukin-11 precursor RX_link

http://www.rxlist.com/cgi/generic3/oprelvek.htm

Interleukin-11 precursor fda sheet

Interleukin-11 precursor msds (material safety sheet)

Interleukin-11 precursor Synthesis Reference

No information avaliable

Interleukin-11 precursor Molecular Weight

19047.2

Interleukin-11 precursor Melting Point

No information avaliable

Interleukin-11 precursor H2O Solubility

No information avaliable

Interleukin-11 precursor State

Liquid

Interleukin-11 precursor LogP

-0.070

Interleukin-11 precursor Dosage Forms

Powder for solution; Solution (subcutaneous injection)

Interleukin-11 precursor Indication

Increases reduced platelet levels due to chemotherapy

Interleukin-11 precursor Pharmacology

Oprelvekin is indicated for the prevention of severe thrombocytopenia and the reduction of the need for platelet transfusions following myelosuppressive chemotherapy in adult patients with nonmyeloid malignancies who are at high risk of severe thrombocytopenia. The primary hematopoietic activity of Oprelvekin is stimulation of megakaryocytopoiesis and thrombopoiesis. Oprelvekin has shown potent thrombopoietic activity in individuals with compromised hematopoiesis

Interleukin-11 precursor Absorption

No information avaliable

Interleukin-11 precursor side effects and Toxicity

No information avaliable

Interleukin-11 precursor Patient Information

No information avaliable

Interleukin-11 precursor Organisms Affected

Humans and other mammals